Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cellular Origins

Explore full profile

Enabling patient access to cell therapies for today and tomorrow

Royston, United KingdomFounded 2022Biotech & Life Sciences
Valuation $100–250M Last recorded · 2025
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Cellular Origins and the history behind them.

At a glance

Status
Operational
Founded
2022
Headquarters
Royston, United Kingdom
Employees
105
Open positions
4
Dealroom signal
56.2/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Cell Therapy, Techbio, Lab Automation, DT and LS, science-based
Technology
Hardware, Deep Tech
Business model
Manufacturing
Client focus
b2b
Links
WebsiteLinkedIn

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Dec 2025 $40M $160M Business Growth Fund · NYBC Ventures · Highland Europe · TTP Group ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Cellular Origins website traffic

Latest recorded traffic for Cellular Origins is 2.4K monthly website visits, down 66.2% over the last three months. Cellular Origins's team grew 32.9% over the past year.

Latest monthly visits2.4K 3-month web change-66.2% 1-year team growth+32.9%
Monthly website visitsDec 2025–Jul 2026
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
Expression of Interest - Cellular OriginsCambridge, England, United Kingdom · Other · Aug 16, 2026 Test & Development EngineerCambridge, England, United Kingdom · Business Intelligence · Aug 9, 2026 Firmware EngineerCambridge, England, United Kingdom · Backend Development · Feb 24, 2026 Finance DirectorRoyston, North Hertfordshire, Hertfordshire, England, United Kingdom · Finance · Jan 17, 2026 Executive AssistantRoyston, North Hertfordshire, Hertfordshire, England, United Kingdom · Human Resources · Jan 16, 2026
5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Reshape BiotechWorld's first AI and robotics powered imaging and analysis platform, researchers can finally automate visual assays and accelerate the pace of research Kongens Lyngby, Denmark Operational 62 $28M $80M
Ochre BioDevelops RNA therapies for chronic liver diseases, a leading cause of death globally Oxford, United Kingdom Operational
Nucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine Oxford, United Kingdom Operational
ChemifyDigitizing chemistry by developing technology to convert chemical code into molecules and vice versa Glasgow, United Kingdom Operational
MytosInfrastructure for fully automated manufacture of any human cell type London, United Kingdom Operational
Research Grid (R.grid)AI-powered automation engine for admin-free clinical trials Norwich, United Kingdom Operational
OppilotechComputational biology platform for first-in-class drug discovery London, United Kingdom Operational
Rosa BiotechAI-driven biosensing and diagnostics company providing outcome-focused biosensing for early disease diagnosis and for use in industrial biotechnology Bristol, United Kingdom Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Johnson & Johnson
  • Business Growth Fund
  • NYBC Ventures
  • Highland Europe
  • TTP Group

Talent

Book a demo to see the people
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇬🇧 United Kingdom95.4%
🇺🇸 United States3.5%
🇨🇦 Canada1.1%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cellular Origins on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cellular Origins’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.